Singapore markets closed

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
39.84-0.73 (-1.80%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close40.57
Open39.97
Bid39.87 x 1100
Ask39.95 x 2200
Day's range39.78 - 40.13
52-week range33.26 - 42.40
Volume9,920,994
Avg. volume4,638,684
Market cap100.227B
Beta (5Y monthly)0.36
PE ratio (TTM)13.57
EPS (TTM)2.94
Earnings date01 Feb 2017 - 06 Feb 2017
Forward dividend & yield2.17 (5.35%)
Ex-dividend date20 May 2021
1y target est47.77
  • Will Emma Walmsley’s radical therapy cure GlaxoSmithKline?
    The Guardian

    Will Emma Walmsley’s radical therapy cure GlaxoSmithKline?

    Will Emma Walmsley’s radical therapy cure GlaxoSmithKline?. The boss’s plan to divide the pharma giant has support – but her own position may hinge on a crucial presentation this week

  • Financial Times

    GSK faces struggle to convince investors as activist Elliott lurks

    Emma Walmsley, GlaxoSmithKline chief executive, faces a struggle to win over key shareholders after Elliott Management attracted converts for radical change at the pharma group, according to leading investors. Ahead of GSK’s investor day next week, activist investor Elliott has sown doubt about whether Walmsley should stay to push through the transformation planned for the group after it spun off its consumer health division last year.

  • Pharma Stock Roundup: AZN COVID-19 Antibody Cocktail Failure, GSK New Cancer Deal
    Zacks

    Pharma Stock Roundup: AZN COVID-19 Antibody Cocktail Failure, GSK New Cancer Deal

    AstraZeneca's (AZN) phase III study on COVID-19 antibody cocktail fails to meet primary goal. Glaxo (GSK) signs a new co-development/commercialization deal for a cancer candidate with iTeos Therapeutics.